HAVN Life Sciences Inc. (HAVLF)

USD 0.01

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2023 2022 2021 2020
Revenue - 276.47 Thousand - -
Cost of Revenue - 186.78 Thousand 4.6 Million -
Gross Profit - 89.69 Thousand -4.6 Million -
Operating Expenses - 9.9 Million 24.34 Million 41.12 Thousand
Selling, General and Administrative Expenses - 8.66 Million 19.4 Million 41.12 Thousand
Research and Development Expenses - 655.8 Thousand 332.57 Thousand -
Other Expenses - - - -
Cost and Expenses - 10.08 Million 24.34 Million 41.12 Thousand
Operating Income - -9.81 Million -30.35 Million -40.57 Thousand
Interest Expense - 64.14 Thousand 17.49 Thousand -
Income Tax Expense - 64.14 Thousand 17.49 Thousand -206.29 Thousand
Earnings before Tax - -22.44 Million -30.38 Million -40.57 Thousand
Net Income - -22.44 Million -30.38 Million -40.57 Thousand
Earnings Per Share Basic - -5.25 -8.47 -0.02
Earnings Per Share Diluted - -5.25 -8.47 -0.02
Weighted Average Shares Outstanding - 4.27 Million 3.58 Million 2.22 Million
Weighted Average Shares Outstanding (Diluted) - 4.27 Million 3.58 Million 2.22 Million
Gross Margin - 0.32 - -
EBIT Margin - -33.29 - -
Profit Margin - -81.18 - -
EBITDA - -9.2 Million -14.84 Million -
Earnings Before Tax Margin - -35.48 - -

Income Statement Charts